Ranbaxy Roundup: R&D Approvals, Brand Decisions, Sun Trading Denial
This article was originally published in PharmAsia News
Executive Summary
Long before Sun Pharmaceutical's major purchase of Ranbaxy Laboratories receives antitrust clearances and is completed, decisions are being reported that have the Ranbaxy brand disappearing in some places as routine regulatory activity goes on.